Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2015

Go back to Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter Ended March 31, 2015

Enanta Pharma (ENTA) Reports Q2 EPS of $1.49

May 7, 2015 9:09 AM EDT

Enanta Pharma (NASDAQ: ENTA) reported Q2 EPS of $1.49, may note compare to the analyst estimate of $1.76. Revenue for the quarter came in at $57.4 million versus the consensus estimate of $63.4 million.

For earnings history and earnings-related data on Enanta Pharma (ENTA) click here.

... More